
Britain’s competition watchdog on Monday launched an investigation into the US travel technology provider Sabre’s proposed $360 million acquisition of smaller rival Farelogix, saying the deal could raise prices for platforms used by airlines and travel agents to sell tickets.
The UK Competition and Markets Authority’s investigation follows an initial review of the deal by the regulator last month and comes two weeks after the US Justice Department sued to block the merger, escalating pressure on the companies to call off the combination.
Both Sabre and Farelogix provide information technology systems that allow hotel and airline bookings through travel agencies.
“We’ve found Sabre’s proposed takeover of Farelogix could lead to higher prices for IT systems used by airlines & travel agents …,” the UK watchdog said, adding that it had referred the deal “for an in-depth investigation.”
Sabre, which planned to close the merger by Aug. 21, last month extended the termination date of the acquisition agreement to April 30 to allow time for any challenges to be resolved.
Full Content: Euro News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas